Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Levels of Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and / or Overweight, and / or Obesity

NCT04768803 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT04768803
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04768803 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Levels of Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and / or Overweight, and / or Obesity
Lead sponsor
University Hospital, Toulouse
Phase
Observational
Overall status
Unknown status
Start date
June 10, 2021
Completion date
December 15, 2023
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

angelman syndrome, epilepsy, prader-willi syndrome, smith-magenis syndrome, x fragile syndrome